Here are two stocks with buy rank and strong value characteristics for investors to consider today, March 4th:  

Catalyst Pharmaceuticals (CPRX Quick QuoteCPRX - Free Report) : This commercial-stage biopharmaceutical company, which is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.

Catalyst Pharmaceuticals, Inc. Price and Consensus

Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote

Catalyst Pharmaceuticals has a price-to-earnings ratio (P/E) of 8.49 compared with 22.04 for the S&P. The company possesses a Value Score of A.

Catalyst Pharmaceuticals, Inc. PE Ratio (TTM)

Catalyst Pharmaceuticals, Inc. pe-ratio-ttm | Catalyst Pharmaceuticals, Inc. Quote

XP (XP Quick QuoteXP - Free Report) : This technology-driven financial services platform, which offers financial products and services primarily in Brazil, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.

XP Inc. Price and Consensus

XP Inc. price-consensus-chart | XP Inc. Quote

XP has a price-to-earnings ratio (P/E) of 10.06 compared with 22.04 for the S&P. The company possesses a Value Score of A.

XP Inc. PE Ratio (TTM)

XP Inc. pe-ratio-ttm | XP Inc. Quote

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.